Bhattacharya S. Formulation Design and Development of Anti-EGFR-BSA-CYP-SLNs In Situ Gel for Nasal Administration. AJP [Internet]. 2016 Dec. 29 [cited 2024 Apr. 30];10(04). Available from: http://www.asiapharmaceutics.info/index.php/ajp/article/view/927